O	O	O	0	16	Characterization	Characterization	B-NP	NN	O	0	ROOT	O
O	O	O	17	19	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	20	21	5	5	B-NP	CD	B-DNA	5	NMOD	B-DNA
O	O	O	21	22	'	'	I-NP	SYM	I-DNA	5	NMOD	I-DNA
O	O	O	23	26	end	end	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	O	27	29	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	30	35	human	human	B-NP	JJ	B-DNA	10	NMOD	B-DNA
T1	B-Protein	B-Protein	36	47	thromboxane	thromboxane	I-NP	NN	I-DNA	10	NMOD	I-DNA
T1	I-Protein	I-Protein	48	56	receptor	receptor	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	O	57	61	gene	gene	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	61	62	.	.	O	.	O	1	P	O

O	O	O	63	77	Organizational	Organizational	B-NP	JJ	O	2	NMOD	O
O	O	O	78	86	analysis	analysis	I-NP	NN	O	4	NMOD	O
O	O	O	87	90	and	and	I-NP	CC	O	4	NMOD	O
O	O	O	91	98	mapping	mapping	I-NP	NN	O	0	ROOT	O
O	O	O	99	101	of	of	B-PP	IN	O	4	NMOD	O
T19,T20	B-Entity,B-Entity	B-Entity,B-Entity	102	109	protein	protein	B-NP	NN	B-protein	8	NMOD	B-protein
T19,T20	I-Entity,I-Entity	I-Entity,I-Entity	110	116	kinase	kinase	I-NP	NN	I-protein	8	NMOD	I-protein
T19,T20	I-Entity,I-Entity	I-Entity,I-Entity	117	118	C	C	I-NP	NN	I-protein	12	NMOD	I-protein
T19	I-Entity	I-Entity	118	119	-	-	B-VP	HYPH	O	12	P	O
T19	I-Entity	I-Entity	119	120	-	-	B-NP	HYPH	B-DNA	12	NMOD	B-DNA
T19	I-Entity	I-Entity	120	130	responsive	responsive	I-NP	JJ	I-DNA	12	NMOD	I-DNA
T19	I-Entity	I-Entity	131	139	elements	element	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	O	140	150	regulating	regulate	B-VP	VBG	O	12	NMOD	O
O	O	O	151	161	expression	expression	B-NP	NN	O	13	OBJ	O
O	O	O	162	164	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	165	174	platelets	platelet	B-NP	NNS	B-cell_type	15	PMOD	B-cell_type
O	O	O	174	175	.	.	O	.	O	4	P	O

O	O	O	177	185	Platelet	Platelet	B-NP	NN	B-protein	3	NMOD	B-protein
T2	B-Protein	B-Protein	186	197	thromboxane	thromboxane	I-NP	NN	I-protein	3	NMOD	I-protein
T2	I-Protein	I-Protein	198	207	receptors	receptor	I-NP	NNS	I-protein	4	SUB	I-protein
O	O	O	208	211	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	212	219	acutely	acutely	B-VP	RB	O	4	VMOD	O
O	O	O	220	223	and	and	I-VP	CC	O	5	AMOD	O
O	O	O	224	234	reversibly	reversibly	I-VP	RB	O	5	AMOD	O
O	O	O	235	246	upregulated	upregulate	I-VP	VBN	O	4	VC	O
O	O	O	247	252	after	after	B-PP	IN	O	8	VMOD	O
O	O	O	253	258	acute	acute	B-NP	JJ	O	12	NMOD	O
O	O	O	259	269	myocardial	myocardial	I-NP	JJ	O	12	NMOD	O
O	O	O	270	280	infarction	infarction	I-NP	NN	O	9	PMOD	O
O	O	O	280	281	.	.	O	.	O	4	P	O

O	O	O	282	284	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	285	294	determine	determine	I-VP	VB	O	13	VMOD	O
O	O	O	295	297	if	if	B-SBAR	IN	O	2	VMOD	O
O	O	O	298	306	platelet	platelet	B-NP	NN	B-protein	7	SUB	B-protein
T3	B-Protein	B-Protein	307	318	thromboxane	thromboxane	I-NP	NN	I-protein	6	NMOD	I-protein
T3	I-Protein	I-Protein	319	328	receptors	receptor	I-NP	NNS	I-protein	4	NMOD	I-protein
O	O	O	329	332	are	be	B-VP	VBP	O	3	SBAR	O
O	O	O	333	338	under	under	B-PP	IN	O	7	PRD	O
O	O	O	339	354	transcriptional	transcriptional	B-NP	JJ	O	10	NMOD	O
O	O	O	355	362	control	control	I-NP	NN	O	8	PMOD	O
O	O	O	362	363	,	,	O	,	O	13	P	O
O	O	O	364	366	we	we	B-NP	PRP	O	13	SUB	O
O	O	O	367	375	isolated	isolate	B-VP	VBD	O	0	ROOT	O
O	O	O	376	379	and	and	O	CC	O	13	VMOD	O
O	O	O	380	393	characterized	characterize	B-VP	VBD	O	13	VMOD	O
T21	B-Entity	B-Entity	394	399	human	human	B-NP	JJ	B-DNA	19	NMOD	B-DNA
T21	I-Entity	I-Entity	400	407	genomic	genomic	I-NP	JJ	I-DNA	19	NMOD	I-DNA
T21	I-Entity	I-Entity	408	411	DNA	DNA	I-NP	NN	I-DNA	19	NMOD	I-DNA
T21	I-Entity	I-Entity	412	418	clones	clone	I-NP	NNS	I-DNA	13	VMOD	I-DNA
O	O	O	419	429	containing	contain	B-VP	VBG	O	19	NMOD	O
O	O	O	430	433	the	the	B-NP	DT	O	25	NMOD	O
T22	B-Entity	B-Entity	434	435	5	5	I-NP	CD	B-DNA	25	NMOD	B-DNA
T22	I-Entity	I-Entity	435	436	'	'	I-NP	SYM	I-DNA	25	NMOD	I-DNA
T22	I-Entity	I-Entity	437	445	flanking	flanking	I-NP	NN	I-DNA	25	NMOD	I-DNA
T22	I-Entity	I-Entity	446	452	region	region	I-NP	NN	I-DNA	20	OBJ	I-DNA
O	O	O	453	455	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	456	459	the	the	B-NP	DT	O	30	NMOD	O
T4	B-Protein	B-Protein	460	471	thromboxane	thromboxane	I-NP	NN	B-DNA	30	NMOD	B-DNA
T4	I-Protein	I-Protein	472	480	receptor	receptor	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	481	485	gene	gene	I-NP	NN	I-DNA	26	PMOD	I-DNA
O	O	O	485	486	.	.	O	.	O	13	P	O

O	O	O	487	490	The	The	B-NP	DT	O	5	NMOD	O
T23	B-Entity	B-Entity	491	495	exon	exon	I-NP	NN	B-DNA	5	NMOD	B-DNA
T23	I-Entity	I-Entity	495	496	-	-	I-NP	HYPH	I-DNA	5	NMOD	I-DNA
T23	I-Entity	I-Entity	496	502	intron	intron	I-NP	NN	I-DNA	5	NMOD	I-DNA
T23	I-Entity	I-Entity	503	512	structure	structure	I-NP	NN	I-DNA	16	SUB	I-DNA
O	O	O	513	515	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	516	519	the	the	B-NP	DT	O	10	NMOD	O
T24	B-Entity	B-Entity	520	521	5	5	I-NP	CD	B-DNA	10	NMOD	B-DNA
T24	I-Entity	I-Entity	521	522	'	'	I-NP	SYM	I-DNA	10	NMOD	I-DNA
T24	I-Entity	I-Entity	523	530	portion	portion	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	531	533	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	534	537	the	the	B-NP	DT	O	15	NMOD	O
T5	B-Protein	B-Protein	538	549	thromboxane	thromboxane	I-NP	NN	B-DNA	15	NMOD	B-DNA
T5	I-Protein	I-Protein	550	558	receptor	receptor	I-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	O	559	563	gene	gene	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	564	567	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	568	578	determined	determine	I-VP	VBN	O	16	VC	O
O	O	O	579	588	initially	initially	B-ADVP	RB	O	17	VMOD	O
O	O	O	589	591	by	by	B-PP	IN	O	17	VMOD	O
O	O	O	592	601	comparing	compare	B-VP	VBG	O	19	PMOD	O
O	O	O	602	605	the	the	B-NP	DT	O	23	NMOD	O
T25	B-Entity	B-Entity	606	616	nucleotide	nucleotide	I-NP	NN	B-DNA	23	NMOD	B-DNA
T25	I-Entity	I-Entity	617	625	sequence	sequence	I-NP	NN	I-DNA	20	OBJ	I-DNA
O	O	O	626	628	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	629	632	the	the	B-NP	DT	O	24	PMOD	O
O	O	O	633	634	5	5	I-NP	CD	B-DNA	25	NMOD	B-DNA
O	O	O	634	635	'	'	I-NP	SYM	I-DNA	26	NMOD	I-DNA
O	O	O	636	644	flanking	flank	B-VP	VBG	I-DNA	27	NMOD	I-DNA
O	O	O	645	652	genomic	genomic	B-NP	JJ	I-DNA	30	NMOD	I-DNA
O	O	O	653	658	clone	clone	I-NP	NN	I-DNA	28	OBJ	I-DNA
O	O	O	659	663	with	with	B-PP	IN	O	28	VMOD	O
O	O	O	664	668	that	that	B-NP	DT	O	31	PMOD	O
O	O	O	669	671	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	672	673	a	a	B-NP	DT	O	40	NMOD	O
O	O	O	674	679	novel	novel	I-NP	JJ	B-DNA	40	NMOD	B-DNA
O	O	O	680	685	human	human	I-NP	JJ	I-DNA	40	NMOD	I-DNA
O	O	O	686	693	uterine	uterine	I-NP	JJ	I-DNA	40	NMOD	I-DNA
T6	B-Protein	B-Protein	694	705	thromboxane	thromboxane	I-NP	NN	I-DNA	40	NMOD	I-DNA
T6	I-Protein	I-Protein	706	714	receptor	receptor	I-NP	NN	I-DNA	40	NMOD	I-DNA
O	O	O	715	719	cDNA	cDNA	I-NP	NN	I-DNA	33	PMOD	I-DNA
O	O	O	720	724	that	that	B-NP	WDT	O	40	NMOD	O
O	O	O	725	733	extended	extend	B-VP	VBD	O	41	SBAR	O
O	O	O	734	737	the	the	B-NP	DT	O	44	NMOD	O
O	O	O	738	742	mRNA	mRNA	I-NP	NN	B-RNA	42	OBJ	B-RNA
T26	B-Entity	B-Entity	743	746	141	141	I-NP	CD	B-DNA	46	NMOD	B-DNA
T26	I-Entity	I-Entity	747	749	bp	bp	I-NP	NN	I-DNA	42	VMOD	I-DNA
T26	I-Entity	I-Entity	750	757	further	further	B-ADVP	RB	I-DNA	46	NMOD	I-DNA
T26	I-Entity	I-Entity	758	766	upstream	upstream	I-ADVP	RB	I-DNA	46	NMOD	I-DNA
O	O	O	767	771	than	than	B-PP	IN	O	46	NMOD	O
O	O	O	772	775	the	the	B-NP	DT	O	55	NMOD	O
O	O	O	776	786	previously	previously	I-NP	RB	O	52	AMOD	O
O	O	O	787	797	identified	identify	I-NP	VBN	O	55	NMOD	O
O	O	O	798	803	human	human	I-NP	JJ	B-DNA	55	NMOD	B-DNA
O	O	O	804	813	placental	placental	I-NP	JJ	I-DNA	55	NMOD	I-DNA
O	O	O	814	818	cDNA	cDNA	I-NP	NN	I-DNA	49	PMOD	I-DNA
O	O	O	818	819	.	.	O	.	O	16	P	O

O	O	O	820	821	A	A	B-NP	DT	O	5	NMOD	O
O	O	O	822	827	major	major	I-NP	JJ	B-DNA	5	NMOD	B-DNA
T27	B-Entity	B-Entity	828	841	transcription	transcription	I-NP	NN	I-DNA	5	NMOD	I-DNA
T27	I-Entity	I-Entity	842	852	initiation	initiation	I-NP	NN	I-DNA	5	NMOD	I-DNA
T27	I-Entity	I-Entity	853	857	site	site	I-NP	NN	I-DNA	6	SUB	I-DNA
O	O	O	858	861	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	862	869	located	locate	I-VP	VBN	O	6	PRD	O
O	O	O	870	872	in	in	B-PP	IN	O	7	AMOD	O
O	O	O	873	878	three	three	B-NP	CD	O	11	NMOD	O
O	O	O	879	884	human	human	I-NP	JJ	O	11	NMOD	O
O	O	O	885	892	tissues	tissue	I-NP	NNS	O	8	PMOD	O
O	O	O	893	906	approximately	approximately	B-NP	RB	O	14	NMOD	O
T28	B-Entity	B-Entity	907	910	560	560	I-NP	CD	B-DNA	14	NMOD	B-DNA
T28	I-Entity	I-Entity	911	913	bp	bp	I-NP	NN	I-DNA	23	NMOD	I-DNA
T28	I-Entity	I-Entity	914	922	upstream	upstream	B-ADVP	RB	I-DNA	14	NMOD	I-DNA
O	O	O	923	927	from	from	B-PP	IN	O	14	NMOD	O
O	O	O	928	931	the	the	B-NP	DT	O	20	NMOD	O
T29	B-Entity	B-Entity	932	943	translation	translation	I-NP	NN	B-DNA	20	NMOD	B-DNA
T29	I-Entity	I-Entity	944	954	initiation	initiation	I-NP	NN	I-DNA	20	NMOD	I-DNA
T29	I-Entity	I-Entity	955	960	codon	codon	I-NP	NN	I-DNA	16	PMOD	I-DNA
O	O	O	961	964	and	and	O	CC	O	23	NMOD	O
T30	B-Entity	B-Entity	965	968	380	380	B-NP	CD	B-DNA	23	NMOD	B-DNA
T30	I-Entity	I-Entity	969	971	bp	bp	I-NP	NN	I-DNA	7	AMOD	I-DNA
T30	I-Entity	I-Entity	972	980	upstream	upstream	B-ADVP	RB	I-DNA	23	NMOD	I-DNA
O	O	O	981	985	from	from	B-PP	IN	O	23	NMOD	O
O	O	O	986	989	any	any	B-NP	DT	O	31	NMOD	O
O	O	O	990	1000	previously	previously	I-NP	RB	O	28	AMOD	O
O	O	O	1001	1011	identified	identify	I-NP	VBN	O	31	NMOD	O
T31	B-Entity	B-Entity	1012	1025	transcription	transcription	I-NP	NN	B-DNA	31	NMOD	B-DNA
T31	I-Entity	I-Entity	1026	1036	initiation	initiation	I-NP	NN	I-DNA	31	NMOD	I-DNA
T31	I-Entity	I-Entity	1037	1041	site	site	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	O	1041	1042	.	.	O	.	O	6	P	O

O	O	O	1043	1046	The	The	B-NP	DT	O	4	NMOD	O
T7	B-Protein	B-Protein	1047	1058	thromboxane	thromboxane	I-NP	NN	B-DNA	4	NMOD	B-DNA
T7	I-Protein	I-Protein	1059	1067	receptor	receptor	I-NP	NN	I-DNA	4	NMOD	I-DNA
O	O	O	1068	1072	gene	gene	I-NP	NN	I-DNA	5	SUB	I-DNA
O	O	O	1073	1076	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	1077	1084	neither	neither	O	CC	O	13	NMOD	O
O	O	O	1085	1086	a	a	B-NP	DT	O	8	NMOD	O
T32	B-Entity	B-Entity	1087	1091	TATA	TATA	I-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	O	1092	1095	nor	nor	O	CC	O	13	NMOD	O
O	O	O	1096	1097	a	a	B-NP	DT	O	13	NMOD	O
T33	B-Entity	B-Entity	1098	1102	CAAT	CAAT	I-NP	NN	B-DNA	13	NMOD	B-DNA
T33	I-Entity	I-Entity	1103	1112	consensus	consensus	I-NP	NN	I-DNA	13	NMOD	I-DNA
T33	I-Entity	I-Entity	1113	1117	site	site	I-NP	NN	I-DNA	5	OBJ	I-DNA
O	O	O	1117	1118	.	.	O	.	O	5	P	O

O	O	O	1119	1127	Promoter	Promoter	B-NP	NN	O	2	NMOD	O
O	O	O	1128	1136	function	function	I-NP	NN	O	14	SUB	O
O	O	O	1137	1139	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1140	1143	the	the	B-NP	DT	O	8	NMOD	O
T34	B-Entity	B-Entity	1144	1145	5	5	I-NP	CD	B-DNA	8	NMOD	B-DNA
T34	I-Entity	I-Entity	1145	1146	'	'	I-NP	SYM	I-DNA	8	NMOD	I-DNA
T34	I-Entity	I-Entity	1147	1155	flanking	flanking	I-NP	NN	I-DNA	8	NMOD	I-DNA
T34	I-Entity	I-Entity	1156	1162	region	region	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	1163	1165	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1166	1169	the	the	B-NP	DT	O	13	NMOD	O
T8	B-Protein	B-Protein	1170	1181	thromboxane	thromboxane	I-NP	NN	B-DNA	13	NMOD	B-DNA
T8	I-Protein	I-Protein	1182	1190	receptor	receptor	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	O	1191	1195	gene	gene	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	O	1196	1199	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1200	1209	evaluated	evaluate	I-VP	VBN	O	14	VC	O
O	O	O	1210	1212	by	by	B-PP	IN	O	15	VMOD	O
O	O	O	1213	1225	transfection	transfection	B-NP	NN	O	16	PMOD	O
O	O	O	1226	1228	of	of	B-PP	IN	O	17	NMOD	O
T9	B-Protein	B-Protein	1229	1240	thromboxane	thromboxane	B-NP	NN	B-DNA	22	NMOD	B-DNA
T9	I-Protein	I-Protein	1241	1249	receptor	receptor	I-NP	NN	I-DNA	22	NMOD	I-DNA
O	O	O	1250	1254	gene	gene	I-NP	NN	I-DNA	22	NMOD	I-DNA
O	O	O	1255	1263	promoter	promoter	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	1263	1264	/	/	B-VP	SYM	O	30	P	O
T10	B-Protein	B-Protein	1264	1279	chloramphenicol	chloramphenicol	B-NP	NN	B-DNA	25	NMOD	B-DNA
T10	I-Protein	I-Protein	1280	1297	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	1298	1299	(	(	O	(	I-DNA	30	NMOD	I-DNA
T11	B-Protein	B-Protein	1299	1302	CAT	CAT	B-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	1302	1303	)	)	O	)	I-DNA	30	NMOD	I-DNA
O	O	O	1304	1311	chimera	chimera	B-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	1312	1320	plasmids	plasmid	I-NP	NNS	I-DNA	18	PMOD	I-DNA
O	O	O	1321	1325	into	into	B-PP	IN	O	17	NMOD	O
O	O	O	1326	1334	platelet	platelet	B-NP	NN	B-cell_type	36	NMOD	B-cell_type
O	O	O	1334	1335	-	-	B-NP	HYPH	O	36	P	O
O	O	O	1335	1339	like	like	I-NP	JJ	O	36	NMOD	O
O	O	O	1340	1344	K562	K562	I-NP	NN	B-cell_line	36	NMOD	B-cell_line
O	O	O	1345	1350	cells	cell	I-NP	NNS	I-cell_line	31	PMOD	I-cell_line
O	O	O	1350	1351	.	.	O	.	O	14	P	O

T12	B-Protein	B-Protein	1352	1363	Thromboxane	Thromboxane	B-NP	NN	O	4	NMOD	O
T12	I-Protein	I-Protein	1364	1372	receptor	receptor	I-NP	NN	O	4	NMOD	O
T35	B-Entity	B-Entity	1373	1381	promoter	promoter	I-NP	NN	O	4	NMOD	O
O	O	O	1382	1390	activity	activity	I-NP	NN	O	12	SUB	O
O	O	O	1390	1391	,	,	O	,	O	4	P	O
O	O	O	1392	1394	as	as	B-SBAR	IN	O	12	VMOD	O
O	O	O	1395	1403	assessed	assess	B-VP	VBN	O	6	SBAR	O
O	O	O	1404	1406	by	by	B-PP	IN	O	7	VMOD	O
T13	B-Protein	B-Protein	1407	1410	CAT	CAT	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1411	1421	expression	expression	I-NP	NN	O	8	PMOD	O
O	O	O	1421	1422	,	,	O	,	O	12	P	O
O	O	O	1423	1426	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1427	1437	relatively	relatively	B-ADJP	RB	O	14	AMOD	O
O	O	O	1438	1442	weak	weak	I-ADJP	JJ	O	12	PRD	O
O	O	O	1443	1446	but	but	O	CC	O	12	VMOD	O
O	O	O	1447	1450	was	be	B-VP	VBD	O	12	VMOD	O
O	O	O	1451	1464	significantly	significantly	I-VP	RB	O	16	VMOD	O
O	O	O	1465	1473	enhanced	enhance	I-VP	VBN	O	16	VC	O
O	O	O	1474	1476	by	by	B-PP	IN	O	18	VMOD	O
O	O	O	1477	1484	phorbol	phorbol	B-NP	NN	O	22	NMOD	O
O	O	O	1485	1490	ester	ester	I-NP	NN	O	22	NMOD	O
O	O	O	1491	1500	treatment	treatment	I-NP	NN	O	19	PMOD	O
O	O	O	1500	1501	.	.	O	.	O	12	P	O

O	O	O	1502	1512	Functional	Functional	B-NP	JJ	O	2	NMOD	O
O	O	O	1513	1521	analysis	analysis	I-NP	NN	O	15	NMOD	O
O	O	O	1522	1524	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1525	1526	5	5	B-NP	CD	B-DNA	7	NMOD	B-DNA
O	O	O	1526	1527	'	'	I-NP	SYM	I-DNA	7	NMOD	I-DNA
O	O	O	1528	1536	deletion	deletion	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	1537	1547	constructs	construct	I-NP	NNS	I-DNA	3	PMOD	I-DNA
O	O	O	1548	1550	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	1551	1562	transfected	transfecte	B-NP	VBN	O	11	NMOD	O
O	O	O	1563	1567	K562	K562	I-NP	NN	B-cell_line	11	NMOD	B-cell_line
O	O	O	1568	1573	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	O	1574	1577	and	and	O	CC	O	15	NMOD	O
O	O	O	1578	1581	gel	gel	B-NP	NN	O	15	NMOD	O
O	O	O	1582	1590	mobility	mobility	I-NP	NN	O	15	NMOD	O
O	O	O	1591	1596	shift	shift	I-NP	NN	O	16	SUB	O
O	O	O	1597	1606	localized	localize	B-VP	VBD	O	0	ROOT	O
O	O	O	1607	1610	the	the	B-NP	DT	O	23	NMOD	O
T36	B-Entity	B-Entity	1611	1616	major	major	I-NP	JJ	B-DNA	20	NMOD	B-DNA
T36	I-Entity	I-Entity	1617	1624	phorbol	phorbol	I-NP	NN	I-DNA	20	NMOD	I-DNA
T36	I-Entity	I-Entity	1625	1630	ester	ester	I-NP	NN	I-DNA	23	NMOD	I-DNA
T36	I-Entity	I-Entity	1630	1631	-	-	B-NP	HYPH	I-DNA	23	NMOD	I-DNA
T36	I-Entity	I-Entity	1631	1641	responsive	responsive	I-NP	JJ	I-DNA	23	NMOD	I-DNA
T36	I-Entity	I-Entity	1642	1648	motifs	motif	I-NP	NNS	I-DNA	16	OBJ	I-DNA
O	O	O	1649	1651	in	in	B-PP	IN	O	23	NMOD	O
O	O	O	1652	1655	the	the	B-NP	DT	O	29	NMOD	O
T14	B-Protein	B-Protein	1656	1667	thromboxane	thromboxane	I-NP	NN	B-DNA	29	NMOD	B-DNA
T14	I-Protein	I-Protein	1668	1676	receptor	receptor	I-NP	NN	I-DNA	29	NMOD	I-DNA
O	O	O	1677	1681	gene	gene	I-NP	NN	I-DNA	29	NMOD	I-DNA
O	O	O	1682	1690	promoter	promoter	I-NP	NN	I-DNA	24	PMOD	I-DNA
O	O	O	1691	1693	to	to	B-PP	TO	O	16	VMOD	O
O	O	O	1694	1695	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	1696	1703	cluster	cluster	I-NP	NN	O	45	NMOD	O
O	O	O	1704	1706	of	of	B-PP	IN	O	32	NMOD	O
T37,T38	B-Entity,B-Entity	B-Entity,B-Entity	1707	1716	activator	activator	B-NP	NN	B-protein	35	NMOD	B-protein
T37,T38	I-Entity,I-Entity	I-Entity,I-Entity	1717	1724	protein	protein	I-NP	NN	I-protein	33	PMOD	I-protein
T37,T38	I-Entity,I-Entity	I-Entity,I-Entity	1724	1725	-	-	O	HYPH	O	45	P	O
T37,T38	I-Entity,I-Entity	I-Entity,I-Entity	1725	1726	2	2	B-NP	CD	B-DNA	45	NMOD	B-DNA
T37	I-Entity	I-Entity	1727	1728	(	(	O	(	I-DNA	45	NMOD	I-DNA
T37,T39	I-Entity,B-Entity	I-Entity,B-Entity	1728	1730	AP	AP	B-NP	NN	I-DNA	45	NMOD	I-DNA
T37,T39	I-Entity,I-Entity	I-Entity,I-Entity	1730	1731	-	-	O	HYPH	I-DNA	41	P	I-DNA
T37,T39	I-Entity,I-Entity	I-Entity,I-Entity	1731	1732	2	2	O	CD	I-DNA	45	NMOD	I-DNA
T37	I-Entity	I-Entity	1732	1733	)	)	O	)	I-DNA	45	NMOD	I-DNA
T37	I-Entity	I-Entity	1734	1741	binding	binding	B-NP	NN	I-DNA	45	NMOD	I-DNA
T37	I-Entity	I-Entity	1742	1751	consensus	consensus	I-NP	NN	I-DNA	45	NMOD	I-DNA
T37	I-Entity	I-Entity	1752	1757	sites	site	I-NP	NNS	I-DNA	30	PMOD	I-DNA
O	O	O	1758	1765	located	located	B-ADJP	JJ	O	45	NMOD	O
O	O	O	1766	1779	approximately	approximately	B-NP	RB	O	46	AMOD	O
O	O	O	1780	1781	1	1	I-NP	CD	O	47	AMOD	O
O	O	O	1781	1782	.	.	I-NP	.	O	47	P	O
O	O	O	1782	1783	8	8	I-NP	CD	O	47	NMOD	O
O	O	O	1784	1786	kb	kb	I-NP	NN	O	50	PMOD	O
O	O	O	1787	1788	5	5	I-NP	CD	O	51	OBJ	O
O	O	O	1788	1789	'	'	B-NP	SYM	O	52	NMOD	O
O	O	O	1790	1794	from	from	B-PP	IN	O	53	VMOD	O
O	O	O	1795	1798	the	the	B-NP	DT	O	58	NMOD	O
T40	B-Entity	B-Entity	1799	1812	transcription	transcription	I-NP	NN	B-DNA	58	NMOD	B-DNA
T40	I-Entity	I-Entity	1813	1823	initiation	initiation	I-NP	NN	I-DNA	58	NMOD	I-DNA
T40	I-Entity	I-Entity	1824	1828	site	site	I-NP	NN	I-DNA	54	PMOD	I-DNA
O	O	O	1828	1829	.	.	O	.	O	16	P	O

O	O	O	1830	1835	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1836	1843	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	1844	1847	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	1848	1851	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1852	1857	first	first	I-NP	JJ	O	3	PRD	O
O	O	O	1858	1860	to	to	B-VP	TO	O	7	VMOD	O
O	O	O	1861	1870	determine	determine	I-VP	VB	O	5	NMOD	O
O	O	O	1871	1874	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1875	1884	structure	structure	I-NP	NN	O	11	NMOD	O
O	O	O	1885	1888	and	and	I-NP	CC	O	11	NMOD	O
O	O	O	1889	1901	organization	organization	I-NP	NN	O	7	OBJ	O
O	O	O	1902	1904	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1905	1908	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1909	1910	5	5	I-NP	CD	B-DNA	16	NMOD	B-DNA
O	O	O	1910	1911	'	'	I-NP	SYM	I-DNA	16	NMOD	I-DNA
O	O	O	1912	1915	end	end	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	1916	1918	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1919	1922	the	the	B-NP	DT	O	21	NMOD	O
T15	B-Protein	B-Protein	1923	1934	thromboxane	thromboxane	I-NP	NN	B-DNA	21	NMOD	B-DNA
T15	I-Protein	I-Protein	1935	1943	receptor	receptor	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	O	1944	1948	gene	gene	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	O	1949	1952	and	and	O	CC	O	7	VMOD	O
O	O	O	1953	1964	demonstrate	demonstrate	B-VP	VBP	O	7	VMOD	O
O	O	O	1965	1969	that	that	B-SBAR	IN	O	23	VMOD	O
T16	B-Protein	B-Protein	1970	1981	thromboxane	thromboxane	B-NP	NN	B-DNA	27	NMOD	B-DNA
T16	I-Protein	I-Protein	1982	1990	receptor	receptor	I-NP	NN	I-DNA	27	NMOD	I-DNA
O	O	O	1991	1995	gene	gene	I-NP	NN	I-DNA	28	NMOD	I-DNA
O	O	O	1996	2006	expression	expression	I-NP	NN	O	29	SUB	O
O	O	O	2007	2010	can	can	B-VP	MD	O	24	SBAR	O
O	O	O	2011	2013	be	be	I-VP	VB	O	29	VC	O
O	O	O	2014	2023	regulated	regulate	I-VP	VBN	O	30	VC	O
O	O	O	2024	2026	by	by	B-PP	IN	O	31	VMOD	O
O	O	O	2027	2037	activation	activation	B-NP	NN	O	32	PMOD	O
O	O	O	2038	2040	of	of	B-PP	IN	O	33	NMOD	O
T41	B-Entity	B-Entity	2041	2048	protein	protein	B-NP	NN	B-protein	37	NMOD	B-protein
T41	I-Entity	I-Entity	2049	2055	kinase	kinase	I-NP	NN	I-protein	37	NMOD	I-protein
T41	I-Entity	I-Entity	2056	2057	C	C	I-NP	NN	I-protein	34	PMOD	I-protein
O	O	O	2058	2061	via	via	B-PP	IN	O	31	VMOD	O
O	O	O	2062	2071	induction	induction	B-NP	NN	O	38	PMOD	O
O	O	O	2072	2074	of	of	B-PP	IN	O	39	NMOD	O
O	O	O	2075	2077	an	an	B-NP	DT	O	48	NMOD	O
T42	B-Entity	B-Entity	2078	2080	AP	AP	I-NP	NN	B-protein	43	NMOD	B-protein
T42	I-Entity	I-Entity	2080	2081	-	-	B-NP	HYPH	I-protein	48	NMOD	I-protein
T42	I-Entity	I-Entity	2081	2082	2	2	I-NP	CD	I-protein	43	NMOD	I-protein
O	O	O	2082	2083	-	-	I-NP	HYPH	O	48	P	O
O	O	O	2083	2087	like	like	I-NP	JJ	B-protein	48	NMOD	B-protein
O	O	O	2088	2095	nuclear	nuclear	I-NP	JJ	I-protein	48	NMOD	I-protein
O	O	O	2096	2102	factor	factor	I-NP	NN	I-protein	40	PMOD	I-protein
O	O	O	2103	2110	binding	bind	B-VP	VBG	O	48	NMOD	O
O	O	O	2111	2113	to	to	B-PP	TO	O	49	VMOD	O
T43	B-Entity	B-Entity	2114	2122	upstream	upstream	B-NP	JJ	B-DNA	53	NMOD	B-DNA
T43	I-Entity	I-Entity	2123	2131	promoter	promoter	I-NP	NN	I-DNA	53	NMOD	I-DNA
T43	I-Entity	I-Entity	2132	2140	elements	element	I-NP	NNS	I-DNA	50	PMOD	I-DNA
O	O	O	2140	2141	.	.	O	.	O	3	P	O

O	O	O	2142	2147	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	2148	2156	findings	finding	I-NP	NNS	O	4	SUB	O
O	O	O	2157	2165	strongly	strongly	B-VP	RB	O	4	VMOD	O
O	O	O	2166	2173	suggest	suggest	I-VP	VBP	O	0	ROOT	O
O	O	O	2174	2178	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	2179	2182	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	2183	2192	mechanism	mechanism	I-NP	NN	O	20	SUB	O
O	O	O	2193	2196	for	for	B-PP	IN	O	7	NMOD	O
O	O	O	2197	2207	previously	previously	B-NP	RB	O	10	AMOD	O
O	O	O	2208	2217	described	describe	I-NP	VBN	O	11	NMOD	O
O	O	O	2218	2230	upregulation	upregulation	I-NP	NN	O	8	PMOD	O
O	O	O	2231	2233	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	2234	2242	platelet	platelet	B-NP	NN	B-protein	15	NMOD	B-protein
T17	B-Protein	B-Protein	2243	2254	thromboxane	thromboxane	I-NP	NN	I-protein	15	NMOD	I-protein
T17	I-Protein	I-Protein	2255	2264	receptors	receptor	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	O	2265	2270	after	after	B-PP	IN	O	11	NMOD	O
O	O	O	2271	2276	acute	acute	B-NP	JJ	O	19	NMOD	O
O	O	O	2277	2287	myocardial	myocardial	I-NP	JJ	O	19	NMOD	O
O	O	O	2288	2298	infarction	infarction	I-NP	NN	O	16	PMOD	O
O	O	O	2299	2301	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	O	2302	2311	increased	increase	I-VP	VBN	O	20	VC	O
T18	B-Protein	B-Protein	2312	2323	thromboxane	thromboxane	B-NP	NN	B-DNA	24	NMOD	B-DNA
T18	I-Protein	I-Protein	2324	2332	receptor	receptor	I-NP	NN	I-DNA	24	NMOD	I-DNA
O	O	O	2333	2337	gene	gene	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	O	2338	2351	transcription	transcription	I-NP	NN	O	21	OBJ	O
O	O	O	2352	2354	in	in	B-PP	IN	O	25	NMOD	O
O	O	O	2355	2363	platelet	platelet	B-NP	NN	B-cell_type	30	NMOD	B-cell_type
O	O	O	2363	2364	-	-	B-NP	HYPH	I-cell_type	30	NMOD	I-cell_type
O	O	O	2364	2374	progenitor	progenitor	I-NP	NN	I-cell_type	30	NMOD	I-cell_type
O	O	O	2375	2380	cells	cell	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	O	2380	2381	.	.	O	.	O	4	P	O
